| The Discovery of MMP7 Inhibitors Exploiting a Novel Selectivity Trigger | | homo-4-mer | 95-259 | 8×CA; 8×ZN; 8×SO4; 4×TQJ; |
| Assess |
| The Discovery of MMP7 inhibitors Exploiting a Novel Selectivity Trigger | | homo-4-mer | 95-258 | 8×CA; 8×ZN; 4×SO4; 4×TQI; |
| Assess |
| NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7) | | monomer | 18-267 | 2×CA; 2×ZN; |
| Assess |
| NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7) in Complex with Zwitterionic … | | monomer | 20-267 | 2×CA; 2×ZN; 127×PX4; |
| Assess |
| NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7) in Complex with Anionic Membr… | | monomer | 20-267 | 2×CA; 2×ZN; 126×PX4; 6×C3S; |
| Assess |
| proMMP-7 with heparin octasaccharide bridging between domains | | monomer | 21-267 | 1×SGN; 2×CA; 2×ZN; |
| Assess |
| proMMP-7 with heparin octasaccharide bound to the catalytic domain | | monomer | 21-267 | 1×SGN; 2×CA; 2×ZN; |
| Assess |
| Solution Structure of Matrilysin (MMP-7) Complexed to Constraint Conformational Sulfonamide Inhibit… | | monomer | 95-267 | 2×CA; 2×ZN; 1×MDW; |
| Assess |
| Crystal structure of human MMP-7 in complex with inhibitor | | monomer | 95-262 | 2×CA; 2×ZN; |
| Assess |
| Crystal structure of human MMP-7 in complex with inhibitor | | monomer | 95-262 | 2×CA; 2×ZN; |
| Assess |
| Crystal structure of human MMP-7 in complex with inhibitor | | monomer | 95-261 | 2×CA; 2×ZN; |
| Assess |
| Crystal structure of human MMP-7 in complex with inhibitor | | monomer | 95-261 | 2×CA; 2×ZN; |
| Assess |
| Crystal structure of human MMP-7 in complex with inhibitor | | monomer | 95-261 | 2×CA; 2×ZN; 1×IOD; 1×CL; |
| Assess |
| MATRILYSIN COMPLEXED WITH SULFODIIMINE INHIBITOR | | monomer | 95-261 | 2×ZN; 2×CA; 1×SRS; |
| Assess |
| MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR | | monomer | 95-260 | 2×ZN; 2×CA; 1×RRS; |
| Assess |
| MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR | | monomer | 95-260 | 2×ZN; 2×CA; 1×RSS; |
| Assess |